Sundance Strategies (SUND) 10-Q 14 Feb 25 2025 Q3 Quarterly report Financial data

Cover

Cover - $ / shares	9 Months Ended
	Dec. 31, 2024	Feb. 13, 2025
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--03-31
Entity File Number	000-50547
Entity Registrant Name	SUNDANCE STRATEGIES, INC.
Entity Central Index Key	0001171838
Entity Tax Identification Number	88-0515333
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	4626 North 300 West
Entity Address, Address Line Two	Suite No. 365
Entity Address, City or Town	Provo
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84604
City Area Code	(801)
Local Phone Number	717-3935
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	SUND
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		43,063,441
Entity Listing, Par Value Per Share	$ 0.001

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Dec. 31, 2024	Mar. 31, 2024
Current Assets
Cash and cash equivalents	$ 259,620	$ 329,860
Prepaid expenses and other assets	13,650	9,075
Total Assets	273,270	338,935
Current Liabilities
Accounts payable	437,360	447,862
Accrued expenses	1,345,301	433,201
Stock repurchase payable	400,000	400,000
Total Current Liabilities	4,468,169	1,631,063
Long-Term Liabilities
Accrued expenses	601,301	1,357,739
Total Long-Term Liabilities	1,905,851	4,647,797
Total Liabilities	6,374,020	6,278,860
Stockholders’ Deficit
Preferred stock, authorized 10,000,000 shares, par value $0.001; -0- shares issued and outstanding
Common stock, authorized 500,000,000 shares, par value $0.001; 43,063,441 shares issued and outstanding as of December, 31 2024; and 42,258,441 shares issued and oustanding as of March, 31 2024	43,064	42,259
Additional paid-in capital	31,718,877	30,914,682
Accumulated deficit	(37,862,691)	(36,896,866)
Total Stockholders’ Deficit	(6,100,750)	(5,939,925)
Total Liabilities and Stockholders’ Deficit	273,270	338,935
Nonrelated Party [Member]
Current Liabilities
Current portion of notes payable	300,000	300,000
Related Party [Member]
Current Liabilities
Current portion of notes payable	1,985,508	50,000
Long-Term Liabilities
Notes payable, related parties, net of current portion	$ 1,304,550	$ 3,290,058

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2024	Mar. 31, 2024
Statement of Financial Position [Abstract]
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	500,000,000	500,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	43,063,441	42,258,441
Common stock, shares outstanding	43,063,441	42,258,441

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Income from Investments
General and Administrative Expenses	143,513	147,842	503,457	371,839
Loss from Operations	(143,513)	(147,842)	(503,457)	(371,839)
Other Income (Expense)
Loss on extinguishment of debt				(398,920)
Gain on settlement of liabilities				290,000
Interest expense	(87,480)	(110,221)	(262,368)	(316,480)
Financing expense	(30,000)	(105,000)	(200,000)	(105,000)
Total Other Income (Expense)	(117,480)	(215,221)	(462,368)	(530,400)
Loss Before Income Taxes	(260,993)	(363,063)	(965,825)	(902,239)
Income Tax Provision (Benefit)
Net Loss	$ (260,993)	$ (363,063)	$ (965,825)	$ (902,239)
Loss per share:
Loss per share - basic	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.03)
Loss per share - diluted	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.03)
Weighted average shares outstanding - basic	43,063,441	42,237,245	42,702,932	41,693,714
Weighted average shares outstanding - diluted	43,063,441	42,237,245	42,702,932	41,693,714

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Mar. 31, 2023	$ 41,409	$ 28,986,558	$ (35,061,875)	$ (6,033,908)
Balance, shares at Mar. 31, 2023	41,408,441
Warrants issued in connection with debt issuances		73,712		73,712
Warrants issued in connection to extinguishment of debt		398,920		398,920
Net loss			(338,192)	(338,192)
Balance at Jun. 30, 2023	$ 41,409	29,459,190	(35,400,067)	(5,899,468)
Balance, shares at Jun. 30, 2023	41,408,441
Balance at Mar. 31, 2023	$ 41,409	28,986,558	(35,061,875)	(6,033,908)
Balance, shares at Mar. 31, 2023	41,408,441
Net loss				(902,239)
Balance at Dec. 31, 2023	$ 42,259	30,349,325	(35,964,114)	(5,572,530)
Balance, shares at Dec. 31, 2023	42,258,441
Balance at Jun. 30, 2023	$ 41,409	29,459,190	(35,400,067)	(5,899,468)
Balance, shares at Jun. 30, 2023	41,408,441
Warrants issued in connection with debt issuances		40,985		40,985
Net loss			(200,984)	(200,984)
Common stock and warrants issued for cash	$ 200	199,800		200,000
Common stock and warrants issued for cash, shares	200,000
Balance at Sep. 30, 2023	$ 41,609	29,699,975	(35,601,051)	(5,859,467)
Balance, shares at Sep. 30, 2023	41,608,441
Net loss			(363,063)	(363,063)
Common stock and warrants issued for cash	$ 650	649,350		650,000
Common stock and warrants issued for cash, shares	650,000
Balance at Dec. 31, 2023	$ 42,259	30,349,325	(35,964,114)	(5,572,530)
Balance, shares at Dec. 31, 2023	42,258,441
Balance at Mar. 31, 2024	$ 42,259	30,914,682	(36,896,866)	(5,939,925)
Balance, shares at Mar. 31, 2024	42,258,441
Net loss			(436,429)	(436,429)
Common stock and warrants issued for cash	$ 180	179,820		180,000
Common stock and warrants issued for cash, shares	180,000
Balance at Jun. 30, 2024	$ 42,439	31,094,502	(37,333,295)	(6,196,354)
Balance, shares at Jun. 30, 2024	42,438,441
Balance at Mar. 31, 2024	$ 42,259	30,914,682	(36,896,866)	(5,939,925)
Balance, shares at Mar. 31, 2024	42,258,441
Net loss				(965,825)
Balance at Dec. 31, 2024	$ 43,064	31,718,877	(37,862,691)	(6,100,750)
Balance, shares at Dec. 31, 2024	43,063,441
Balance at Jun. 30, 2024	$ 42,439	31,094,502	(37,333,295)	(6,196,354)
Balance, shares at Jun. 30, 2024	42,438,441
Net loss			(268,403)	(268,403)
Common stock and warrants issued for cash	$ 625	624,375		625,000
Common stock and warrants issued for cash, shares	625,000
Balance at Sep. 30, 2024	$ 43,064	31,718,877	(37,601,698)	(5,839,757)
Balance, shares at Sep. 30, 2024	43,063,441
Net loss			(260,993)	(260,993)
Balance at Dec. 31, 2024	$ 43,064	$ 31,718,877	$ (37,862,691)	$ (6,100,750)
Balance, shares at Dec. 31, 2024	43,063,441

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Operating Activities
Net Loss	$ (260,993)	$ (363,063)	$ (965,825)	$ (902,239)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on extinguishment of debt				398,920
Gain on settlement of liabilities				(290,000)
Amortization of debt discount				60,844
Prepaid expenses and other assets			(4,575)	(4,335)
Accounts payable			(10,502)	16
Accrued expenses			155,662	296,531
Net Cash used in Operating Activities			(825,240)	(440,263)
Financing Activities
Proceeds from issuance of common stock and warrants			805,000	850,000
Proceeds from issuance of notes payable, related party				180,950
Repayment of notes payable, related party			(50,000)	(35,000)
Net Cash provided by Financing Activities			755,000	995,950
Net Change in Cash and Cash Equivalents			(70,240)	555,687
Cash and Cash Equivalents at Beginning of Period			329,860	553
Cash and Cash Equivalents at End of Period	$ 259,620	$ 556,240	259,620	556,240
Supplemental disclosure of cash flow information:
Cash paid for interest			150,000
Cash paid for income taxes
Non Cash Financing & Investing Activities, and Other Disclosures
Issued warrants as debt issuance costs				$ 114,697

BASIS OF PRESENTATION, ORGANIZA

BASIS OF PRESENTATION, ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
BASIS OF PRESENTATION, ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	(1) BASIS OF PRESENTATION, ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and reflect the financial position, results of operations and cash flows of the Company. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024, which was filed with the SEC on July 1, 2024. The results from operations for the three- and nine-month period ended December 31, 2024, are not necessarily indicative of the results that may be expected for the fiscal year ended March 31, 2025. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, stockholders’ equity, and cash flows at December 31, 2024, and for all periods presented herein have been made. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in the Company’s financial statements and the accompanying notes. Actual results could materially differ from those estimates. Organization and Nature of Operations Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, and engaged in the retail selling of beverage products to the general public until these endeavors ceased in 2006; it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. (“ANEW LIFE”), a subsidiary of Sundance Strategies, Inc. (“Sundance Strategies”, “the Company”, “we” or “our”). Our historical business model has focused on purchasing or acquiring life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market.” During the latter part of the fiscal year ended March 31, 2021, the Company began developing an additional business offering, providing professional services to specialty structured finance groups, bond issuers and life settlement aggregators. The Company has now assembled an experienced team from the life settlement marketplace, as well as from other areas such as financial services and public financial markets. As a professional services provider, the Company applies industry best practices to advise on the selection of specific portfolios of life insurance policies that are tailored to meet the needs of its clients. The Company’s clients may include bond issuers, bond investors, or other structured finance product issuers. The Company develops strategies and methodologies which include the acquisition of life insurance portfolios, then uses common structured finance techniques and proprietary analytics to structure bonds for issuances, including principal protected bonds. The Company’s goal is to deliver long-term value and profitability to shareholders by growing the Company’s professional services business and asset base, resulting in the ability to pay dividends to its shareholders. The Company has developed an additional business offering working closely with bond placement agents and aggregators to establish various aspects of a proprietary, investment grade bond offering. In this arrangement, the Company participates as the sole originator in the role of structuring and advising on the structure of the proprietary bond instrument. Included in the role of structuring financial assets, the Company uses proprietary analytics to establish the makeup of the rated instrument, including but not limited to, life settlement assets (life insurance policies) and managed cash, and implements a process of selective assembly of the underlying assets and cash management that will meet the policy requirements and analytics. The Company provides current and ongoing resources for all analytics, as well as advisement support for the investment and non-investment grade ratings for the managed asset pool and the managed cash accounts. In its advisory role, the Company is reimbursed for all expenses associated with the structuring and preparation of any bond offering, will receive an advisory payment upon the closing of any bond offering, and then will hold residual rights on the balance of assets once the bond is retired. Significant Accounting Policies There have been no changes to the significant accounting policies of the Company from the information provided in Note 2 of the Notes to Consolidated Financial Statements in the Company’s most recent Form 10-K, except as discussed below. Basic and Diluted Net Income (Loss) Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the periods presented using the treasury stock method. Diluted net loss per common share is computed by including common shares that may be issued subject to existing rights with dilutive potential, when applicable. Potential dilutive common stock equivalents are primarily comprised of potential dilutive shares resulting from convertible debt agreements and common stock warrants. Potentially dilutive shares resulting from convertible debt agreements are evaluated using the if-converted method. Potentially dilutive securities are not included in the calculation of diluted net loss per share for the three- and nine-months ended December 31, 2024, or 2023, because to do so would be anti-dilutive. Potentially dilutive securities outstanding as of December 31, 2024, and 2023, are comprised of warrants convertible into 14,203,573 12,008,544 New Accounting Pronouncements The Company has reviewed all recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.

LIQUIDITY REQUIREMENTS

LIQUIDITY REQUIREMENTS	9 Months Ended
	Dec. 31, 2024
Liquidity Requirements
LIQUIDITY REQUIREMENTS	(2) LIQUIDITY REQUIREMENTS Since the Company’s inception on January 31, 2013, its operations have been primarily financed through sales of equity, debt financing from related parties, and the issuance of notes payable and convertible debentures. As of December 31, 2024, the Company had $ 259,620 329,860 4,265,942 3,000,000 56,000 200,000 105,000 300,000 437,360 The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	(3) FAIR VALUE MEASUREMENTS As defined by ASC Topic 820, “Fair Value Measurements and Disclosures” (“ASC 820”), fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also requires the consideration of differing levels of inputs in the determination of fair values. Those levels of input are summarized as follows: ● Level 1: Quoted prices in active markets for identical assets and liabilities. ● Level 2: Observable inputs other than Level 1 quoted prices, such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. ● Level 3: Unobservable inputs that are supported by little or no market activity. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques as well as instruments for which the determination of fair value requires significant management judgment or estimation. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company did not have any transfers of assets and liabilities between Levels 1, 2 and 3 of the fair value measurement hierarchy during the nine months ended December 31, 2024, and 2023. The Company issues warrants from time to time (see Note 7), which fair value is calculated using Level 3 inputs. Other Financial Instruments The Company’s recorded values of cash and cash equivalents, prepaid expenses and other assets, accounts payable and accrued liabilities approximate their fair values based on their short-term nature. The recorded values of the notes payable and convertible debenture approximate the fair values as the interest rate approximates market interest rates.

NOTES PAYABLE

NOTES PAYABLE	9 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
NOTES PAYABLE	(4) NOTES PAYABLE On April 6, 2021, the Company borrowed $ 300,000 8 April 6, 2023 1,000,000 1.00 3 April 6, 2023, to August 31, 2025 8 89,753

NOTES PAYABLE, RELATED PARTY

NOTES PAYABLE, RELATED PARTY	9 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
NOTES PAYABLE, RELATED PARTY	(5) NOTES PAYABLE, RELATED PARTY As of December 31, 2024, and March 31, 2024, the Company had borrowed $ 3,290,058 3,340,058 986,871 11,925 477,077 1,357,738 Related Party Promissory Notes As of both December 31, 2024, and March 31, 2024, the Company owed $ 826,000 8 563,000 479,120 3,196,332 On July 29, 2021, the Company entered into an unsecured promissory note agreement with Radiant Life, LLC. This agreement was in conjunction with the Company borrowing $ 50,000 8 63,200 Related Party Note Payable and Line of Credit Agreements As of December 31, 2024, and March 31, 2024, the Company owed $ 1,304,550 4,600,000 7.5 477,077 4,418,225 As of December 31, 2024, and March 31, 2024, the Company owed $ 1,159,508 2,130,000 7.5 507,751 3,229,016 As of December 31, 2024, there was no

CONVERTIBLE DEBENTURE AGREEMENT

CONVERTIBLE DEBENTURE AGREEMENT	9 Months Ended
	Dec. 31, 2024
Convertible Debenture Agreement
CONVERTIBLE DEBENTURE AGREEMENT	(6) CONVERTIBLE DEBENTURE AGREEMENT The Company has entered into an 8 3,000,000 Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90-day average closing price of the Company’s common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $ 1.00 June 2, 2016 August 31, 2026 0 124,225

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	9 Months Ended
	Dec. 31, 2024
Equity [Abstract]
STOCKHOLDERS’ EQUITY	(7) STOCKHOLDERS’ EQUITY Common Stock Effective December 6, 2018, three existing stockholders have contributed to the Company a portion of their common shares held at a repurchase price to the Company of $ 0.05 8,000,000 6,000,000 400,000 300,000 400,000 On August 15, 2023, the Company issued a private placement memorandum offering to raise up to $ 1,500,000 0.001 200,000 400,000 400,000 650,000 1,300,000 650,000 Between June 18, 2024, and July 10, 2024, the Company received subscription agreements from seven separate investors, for 805,000 1,610,000 805,000 Warrants to Purchase Common Stock The Company’s related party lenders consist of: Kraig Higginson, the Chairman of the Board of Directors and a stockholder, Radiant Life, LLC, and Mr. Dickman, a board member and stockholder. These holders of the related party unsecured promissory notes hold agreements that provide each related party with common stock warrants upon the lender’s extension of a maturity due date or upon the loaning of additional monies. The number of warrants issued for an extension is based on the following formula: 10,000 warrants per month the due date is extended plus 1 warrant for every $2 of the principal balance outstanding (not including interest) at the time of the extension (rounded to the nearest whole warrant) 5 During the nine months ended December 31, 2024, the Company issued no new warrants to the Chairman of the Board of Directors, Radiant Life, LLC or Mr. Dickman in conjunction with an extension of the maturity dates during the period per the terms outlined above (see note 8). Between June 18, 2024, and July 10, 2024, the Company issued 1,610,000 5 805,000 0.35 During the nine months ended December 31, 2024, 1,450,000 1,000,000 1.00 450,000 0.05 SCHEDULE OF WARRANT OUTSTANDING Number of Warrants Weighted Average Exercise Price ($) Outstanding at March 31, 2024 14,043,573 0.75 Granted to investors for cash 1,610,000 0.35 Expired (1,450,000 ) 0.71 Outstanding at December 31, 2024 14,203,573 0.71 Exercisable at December 31, 2024 14,203,573 0.71 The following table summarizes the warrants issued and outstanding as of December 31, 2024: SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING Exercise Price ($) Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life (Years) Proceeds to Company if Exercised 0.05 3,258,754 3,258,754 0.53 $ 162,939 0.35 3,310,000 3,310,000 4.12 1,158,500 0.41 2,035,029 2,035,029 4.08 1,467,627 1.05 5,049,790 5,049,790 2.73 5,302,280 2.00 50,000 50,000 1.59 100,000 5.00 500,000 500,000 2.07 2,500,000 14,203,573 14,203,573 $ 10,691,346 The shares of common stock issuable upon exercise of the warrants are not registered with the Securities and Exchange Commission and the holders of the warrants do not have registration rights with respect to the warrants or the underlying shares of common stock.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Dec. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	(8) SUBSEQUENT EVENTS On January 3, 2025, the Company agreed to amend the 8 November 30, 2024 to August 31, 2026 Between January 7, 2025, and February 3, 2025, 1,252,000 500,000 0.05 752,000 0.05 On January 26, 2025, the Company negotiated with the Chairman of the Board of Directors to extend the due date of the notes payable and line of credit to November 30, 2026 1,544,550 0.41

BASIS OF PRESENTATION, ORGANI_2

BASIS OF PRESENTATION, ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and reflect the financial position, results of operations and cash flows of the Company. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024, which was filed with the SEC on July 1, 2024. The results from operations for the three- and nine-month period ended December 31, 2024, are not necessarily indicative of the results that may be expected for the fiscal year ended March 31, 2025. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, stockholders’ equity, and cash flows at December 31, 2024, and for all periods presented herein have been made. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in the Company’s financial statements and the accompanying notes. Actual results could materially differ from those estimates.
Organization and Nature of Operations	Organization and Nature of Operations Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, and engaged in the retail selling of beverage products to the general public until these endeavors ceased in 2006; it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. (“ANEW LIFE”), a subsidiary of Sundance Strategies, Inc. (“Sundance Strategies”, “the Company”, “we” or “our”). Our historical business model has focused on purchasing or acquiring life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market.” During the latter part of the fiscal year ended March 31, 2021, the Company began developing an additional business offering, providing professional services to specialty structured finance groups, bond issuers and life settlement aggregators. The Company has now assembled an experienced team from the life settlement marketplace, as well as from other areas such as financial services and public financial markets. As a professional services provider, the Company applies industry best practices to advise on the selection of specific portfolios of life insurance policies that are tailored to meet the needs of its clients. The Company’s clients may include bond issuers, bond investors, or other structured finance product issuers. The Company develops strategies and methodologies which include the acquisition of life insurance portfolios, then uses common structured finance techniques and proprietary analytics to structure bonds for issuances, including principal protected bonds. The Company’s goal is to deliver long-term value and profitability to shareholders by growing the Company’s professional services business and asset base, resulting in the ability to pay dividends to its shareholders. The Company has developed an additional business offering working closely with bond placement agents and aggregators to establish various aspects of a proprietary, investment grade bond offering. In this arrangement, the Company participates as the sole originator in the role of structuring and advising on the structure of the proprietary bond instrument. Included in the role of structuring financial assets, the Company uses proprietary analytics to establish the makeup of the rated instrument, including but not limited to, life settlement assets (life insurance policies) and managed cash, and implements a process of selective assembly of the underlying assets and cash management that will meet the policy requirements and analytics. The Company provides current and ongoing resources for all analytics, as well as advisement support for the investment and non-investment grade ratings for the managed asset pool and the managed cash accounts. In its advisory role, the Company is reimbursed for all expenses associated with the structuring and preparation of any bond offering, will receive an advisory payment upon the closing of any bond offering, and then will hold residual rights on the balance of assets once the bond is retired.
Significant Accounting Policies	Significant Accounting Policies There have been no changes to the significant accounting policies of the Company from the information provided in Note 2 of the Notes to Consolidated Financial Statements in the Company’s most recent Form 10-K, except as discussed below.
Basic and Diluted Net Income (Loss) Per Common Share	Basic and Diluted Net Income (Loss) Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the periods presented using the treasury stock method. Diluted net loss per common share is computed by including common shares that may be issued subject to existing rights with dilutive potential, when applicable. Potential dilutive common stock equivalents are primarily comprised of potential dilutive shares resulting from convertible debt agreements and common stock warrants. Potentially dilutive shares resulting from convertible debt agreements are evaluated using the if-converted method. Potentially dilutive securities are not included in the calculation of diluted net loss per share for the three- and nine-months ended December 31, 2024, or 2023, because to do so would be anti-dilutive. Potentially dilutive securities outstanding as of December 31, 2024, and 2023, are comprised of warrants convertible into 14,203,573 12,008,544
New Accounting Pronouncements	New Accounting Pronouncements The Company has reviewed all recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.

STOCKHOLDERS_ EQUITY (Tables)

STOCKHOLDERS’ EQUITY (Tables)	9 Months Ended
	Dec. 31, 2024
Equity [Abstract]
SCHEDULE OF WARRANT OUTSTANDING	SCHEDULE OF WARRANT OUTSTANDING Number of Warrants Weighted Average Exercise Price ($) Outstanding at March 31, 2024 14,043,573 0.75 Granted to investors for cash 1,610,000 0.35 Expired (1,450,000 ) 0.71 Outstanding at December 31, 2024 14,203,573 0.71 Exercisable at December 31, 2024 14,203,573 0.71
SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING	The following table summarizes the warrants issued and outstanding as of December 31, 2024: SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING Exercise Price ($) Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life (Years) Proceeds to Company if Exercised 0.05 3,258,754 3,258,754 0.53 $ 162,939 0.35 3,310,000 3,310,000 4.12 1,158,500 0.41 2,035,029 2,035,029 4.08 1,467,627 1.05 5,049,790 5,049,790 2.73 5,302,280 2.00 50,000 50,000 1.59 100,000 5.00 500,000 500,000 2.07 2,500,000 14,203,573 14,203,573 $ 10,691,346

BASIS OF PRESENTATION, ORGANI_3

BASIS OF PRESENTATION, ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - shares	9 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Auti-dilutive securities outstanding	14,203,573	12,008,544

LIQUIDITY REQUIREMENTS (Details

LIQUIDITY REQUIREMENTS (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Mar. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Cash assets	$ 259,620		$ 259,620		$ 329,860
Notes payable borrowing capacity	4,265,942		4,265,942
Operating expenses			56,000
Financing expenses	30,000	$ 105,000	200,000	$ 105,000
Additional financing alternatives			300,000
Accounts payable outstanding	437,360		437,360		$ 447,862
Convertible Debenture Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Debt borrowing amount	$ 3,000,000		$ 3,000,000

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narrative) - Unsecured Promissory Note [Member] - Satco International Ltd [Member] - USD ($)	Apr. 06, 2021	Dec. 31, 2024
Short-Term Debt [Line Items]
Notes payable	$ 300,000
Debt instrument, interest rate, stated percentage	8%
Debt instrument maturity date	Apr. 06, 2023
Issuance of warrants	1,000,000
Warrant exercisable price per share	$ 1
Promissory note expiring	3 years
Debt instrument, maturity date, description	April 6, 2023, to August 31, 2025
Interest payable		$ 89,753

NOTES PAYABLE, RELATED PARTY (D

NOTES PAYABLE, RELATED PARTY (Details Narrative) - USD ($)	Jul. 02, 2024	Dec. 31, 2024	Mar. 31, 2024	Jan. 26, 2024	Jul. 29, 2021
Mr Glenn S Dickman [Member]
Short-Term Debt [Line Items]
Number of warrants issued		450,000
Related Party [Member]
Short-Term Debt [Line Items]
Note payable		$ 3,290,058	$ 3,340,058
Short-term accrued interest		986,871	11,925
Long-term accrued interest		477,077	1,357,738
Debt instrument, unamortized discount		0
Related Party [Member] | Unsecured Promissory Note [Member] | Mr Glenn S Dickman [Member]
Short-Term Debt [Line Items]
Note payable		$ 826,000	826,000
Debt instrument interest rate		8%
Number of warrants issued		3,196,332		563,000
Accrued interest		$ 479,120
Radiant Life LLC [Member] | Notes Payable and Lines of Credit Agreement [Member]
Short-Term Debt [Line Items]
Note payable		$ 1,159,508	1,159,508
Debt instrument interest rate		7.50%
Accrued interest		$ 507,751
Number of warrants issued		3,229,016
Radiant Life LLC [Member] | Notes Payable and Lines of Credit Agreement [Member] | Maximum [Member]
Short-Term Debt [Line Items]
Note payable		$ 2,130,000
Radiant Life LLC [Member] | Unsecured Promissory Note [Member]
Short-Term Debt [Line Items]
Note payable					$ 50,000
Debt instrument interest rate					8%
Repayments of long-term debt	$ 63,200
Kraig T. Higginson [Member] | Notes Payable and Lines of Credit Agreement [Member]
Short-Term Debt [Line Items]
Note payable		$ 1,304,550	$ 1,304,550
Debt instrument interest rate		7.50%
Accrued interest		$ 477,077
Number of warrants issued		4,418,225
Kraig T. Higginson [Member] | Notes Payable and Lines of Credit Agreement [Member] | Maximum [Member]
Short-Term Debt [Line Items]
Note payable		$ 4,600,000

CONVERTIBLE DEBENTURE AGREEME_2

CONVERTIBLE DEBENTURE AGREEMENT (Details Narrative) - Convertible Debenture Agreement [Member] - USD ($)	9 Months Ended
	Dec. 31, 2024	Mar. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Debt borrowing amount	$ 3,000,000
Related Party [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Amount payable		$ 0
Satco International Ltd [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Interest rate	8%
Debt borrowing amount	$ 3,000,000
Description of convertible terms of conversion	Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90-day average closing price of the Company’s common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $1.00 per share
Debt convertible conversion price per share	$ 1
Debt maturity date	Jun. 02, 2016
Amount payable	$ 0
Accrued interest expense	$ 124,225	$ 124,225
Satco International Ltd [Member] | Extended Maturity [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Debt maturity date	Aug. 31, 2026

SCHEDULE OF WARRANT OUTSTANDING

SCHEDULE OF WARRANT OUTSTANDING (Details)	9 Months Ended
	Dec. 31, 2024 $ / shares shares
Equity [Abstract]
Number of Warrants Outstanding, Beginning Balance | shares	14,043,573
Weighted Average Exercise Price, Beginning Balance | $ / shares	$ 0.75
Number of Warrants, Granted in Investors For Cash | shares	1,610,000
Weighted Average Exercise Price, Granted in Investors For Cash | $ / shares	$ 0.35
Number of Warrants, Expired | shares	(1,450,000)
Weighted Average Exercise Price, Expired | $ / shares	$ 0.71
Number of Warrants Outstanding, Ending Balance | shares	14,203,573
Weighted Average Exercise Price, Ending Balance | $ / shares	$ 0.71
Number of Warrants Exercisable | shares	14,203,573
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.71

SCHEDULE OF WARRANTS ISSUED AND

SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING (Details) - USD ($)	9 Months Ended
	Dec. 31, 2024	Mar. 31, 2024
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Outstanding	14,203,573	14,043,573
Warrants Exercisable	14,203,573
Proceeds to Company if Exercised	$ 10,691,346
Exercise Price One [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.05
Warrant Outstanding	3,258,754
Warrants Exercisable	3,258,754
Weighted Average Remaining Contractual Life (Years)	6 months 10 days
Proceeds to Company if Exercised	$ 162,939
Exercise Price Two [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.35
Warrant Outstanding	3,310,000
Warrants Exercisable	3,310,000
Weighted Average Remaining Contractual Life (Years)	4 years 1 month 13 days
Proceeds to Company if Exercised	$ 1,158,500
Exercise Price Three [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.41
Warrant Outstanding	2,035,029
Warrants Exercisable	2,035,029
Weighted Average Remaining Contractual Life (Years)	4 years 29 days
Proceeds to Company if Exercised	$ 1,467,627
Exercise Price Four [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 1.05
Warrant Outstanding	5,049,790
Warrants Exercisable	5,049,790
Weighted Average Remaining Contractual Life (Years)	2 years 8 months 23 days
Proceeds to Company if Exercised	$ 5,302,280
Exercise Price Five [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 2
Warrant Outstanding	50,000
Warrants Exercisable	50,000
Weighted Average Remaining Contractual Life (Years)	1 year 7 months 2 days
Proceeds to Company if Exercised	$ 100,000
Exercise Price Six [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 5
Warrant Outstanding	500,000
Warrants Exercisable	500,000
Weighted Average Remaining Contractual Life (Years)	2 years 25 days
Proceeds to Company if Exercised	$ 2,500,000

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)					1 Months Ended	9 Months Ended
	Oct. 04, 2023	Sep. 20, 2023	Aug. 15, 2023	Dec. 06, 2018	Jul. 10, 2024	Dec. 31, 2024	Dec. 31, 2023	Mar. 31, 2024	Apr. 06, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Repayment to related party						$ 50,000	$ 35,000
Proceeds from issuance of private placement			$ 1,500,000
Common stock, par value			$ 0.001			$ 0.001		$ 0.001
Proceeds from issuance of common stock and warrants						$ 805,000	$ 850,000
Number of warrants expired						1,450,000
Mr Glenn S Dickman [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase of warrants						450,000
Warrant exercise price						$ 0.05
Unsecured Promissory Note [Member] | Satco International Ltd [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase of warrants									1,000,000
Warrant exercise price									$ 1
Related Party Lenders [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant or right, reason for issuance, description						The number of warrants issued for an extension is based on the following formula: 10,000 warrants per month the due date is extended plus 1 warrant for every $2 of the principal balance outstanding (not including interest) at the time of the extension (rounded to the nearest whole warrant)
Warrants expire term						5 years
Unsecured Promissory Note Agreement [Member] | Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of warrants expired						1,450,000
Three Existing Shareholders [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock repurchase, price per share				$ 0.05
Number of shares cancelled/retired				8,000,000
Number of shares owned				6,000,000
Number of stock value repurchased				$ 400,000
Repayment to related party				300,000
Due to related party				$ 400,000
Investor [Member] | Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase during period shares		200,000
Purchase of warrants		400,000
Proceeds from issuance of common stock and warrants		$ 400,000
Three Separate Investors [Member] | Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase during period shares	650,000
Purchase of warrants	1,300,000
Proceeds from issuance of common stock and warrants	$ 650,000
Seven Separate Investors [Member] | Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase during period shares					805,000
Purchase of warrants					1,610,000
Proceeds from issuance of common stock and warrants					$ 805,000
Equity Investors [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase during period shares					805,000
Purchase of warrants					1,610,000
Warrants expire term					5 years
Equity Investor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price					$ 0.35

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - $ / shares			1 Months Ended	9 Months Ended
	Jan. 26, 2025	Jan. 03, 2025	Feb. 03, 2025	Dec. 31, 2024
Subsequent Event [Line Items]
Number of warrants expired				1,450,000
Number of warrants issued				1,610,000
Subsequent Event [Member] | Kraig T. Higginson [Member]
Subsequent Event [Line Items]
Number of warrants expired			1,252,000
Number of warrants issued	1,544,550		500,000
Warrant exercise price	$ 0.41		$ 0.05
Debt instrument maturity date	Nov. 30, 2026
Subsequent Event [Member] | Mr Glenn S Dickman [Member]
Subsequent Event [Line Items]
Number of warrants issued			752,000
Warrant exercise price			$ 0.05
Convertible Debenture Agreement [Member] | Subsequent Event [Member] | Satco International Ltd [Member]
Subsequent Event [Line Items]
Debt instrument, interest rate, stated percentage		8%
Debt instrument, maturity date, description		November 30, 2024 to August 31, 2026